Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

Share Price is delayed by 15 minutes
Get Live Data
4,579.50    35.50 (0.78%)
Bid:
4,582.50
Ask:
4,584.00
Spread: 1.50 (0.033%)
Market Cap: £98.62b
ULVR Live PriceLast checked at - London Stock Exchange

Intraday Unilever Share Chart

Result of AGM

30 Apr 2025 16:08

RNS Number : 8935G
Unilever PLC
30 April 2025
 

London, 30 April 2025

 

 

UNILEVER PLC

 

RESULTS OF ANNUAL GENERAL MEETING

 

 

 

Unilever PLC shareholders today approved each of the resolutions put to the 2025 Annual General Meeting. Resolutions 1 to 15 were passed as ordinary resolutions and resolutions 16 to 19 were passed as special resolutions. Voting was by poll on each resolution and the results are set out below.

 

 

BOARD APPOINTMENTS

 

The following directors stood for election or re-election and were duly elected or re-elected by the shareholders of Unilever PLC:

 

Benoît Potier, Zoe Yujnovich, Fernando Fernandez, Adrian Hennah, Susan Kilsby, Ruby Lu, Judith McKenna, Ian Meakins and Nelson Peltz.

 

 

POLL RESULTS - ANNUAL GENERAL MEETING 30 April 2025

 

 

 

TOTAL VOTES FOR

%

TOTAL VOTES AGAINST

%

TOTAL VOTES CAST

% OF SHARE CAPITAL VALIDLY CAST VOTED FOR AND AGAINST

VOTES WITHHELD

1. To receive the Report and Accounts for the year ended 31 December 2024 together with the Directors' Reports and the Auditor's Report

1,799,634,775

99.23%

13,883,754

0.77%

1,813,518,529

73.84%

3,553,925

2. To approve the Directors' Remuneration Report

1,311,939,513

72.29%

502,912,633

27.71%

1,814,852,146

73.90%

2,222,529

3. To elect Benoît Potier as a Director

1,812,197,831

99.87%

2,397,611

0.13%

1,814,595,442

73.89%

250,686

4. To elect Zoe Yujnovich as a Director

1,811,330,368

99.82%

3,201,110

0.18%

1,814,531,478

73.89%

247,377

5. To re-elect Fernando Fernandez as a Director

1,812,853,767

99.88%

2,246,965

0.12%

1,815,100,732

73.91%

243,186

6. To re-elect Adrian Hennah as a Director

1,685,812,240

92.91%

128,701,746

7.09%

1,814,513,986

73.88%

367,357

7. To re-elect Susan Kilsby as a Director

1,808,866,372

99.69%

5,711,542

0.31%

1,814,577,914

73.89%

261,502

8. To re-elect Ruby Lu as a Director

1,803,637,884

99.39%

11,045,923

0.61%

1,814,683,807

73.89%

239,553

9. To re-elect Judith McKenna as a Director

1,806,431,561

99.55%

8,095,650

0.45%

1,814,527,211

73.89%

219,232

10. To re-elect Ian Meakins as a Director

1,710,039,826

94.85%

92,812,901

5.15%

1,802,852,727

73.41%

9,924,426

11. To re-elect Nelson Peltz as a Director

1,775,756,130

98.03%

35,682,557

1.97%

1,811,438,687

73.76%

2,113,671

12. To reappoint KPMG LLP as Auditor of the Company

1,717,243,698

94.61%

97,806,035

5.39%

1,815,049,733

73.91%

2,045,928

13. To authorise the Directors to fix the remuneration of the Auditor

1,780,180,403

98.07%

34,995,837

1.93%

1,815,176,240

73.91%

1,917,710

14. To authorise political donations and expenditure

1,773,872,062

98.10%

34,267,088

1.90%

1,808,139,150

73.63%

8,956,374

15. To renew the authority to Directors to allot shares

1,701,680,561

94.07%

107,219,254

5.93%

1,808,899,815

73.66%

8,195,045

16. To renew the authority to Directors to disapply pre-emption rights

1,772,649,686

98.03%

35,591,216

1.97%

1,808,240,902

73.63%

8,853,741

17. To renew the authority to Directors to disapply pre-emption rights in connection with acquisitions or capital investments

1,771,903,554

97.65%

42,552,420

2.35%

1,814,455,974

73.88%

2,638,953

18. To renew the authority to the Company to purchase its own shares

1,812,190,140

99.86%

2,599,242

0.14%

1,814,789,382

73.90%

2,305,546

19. To shorten the notice period for General Meetings (other than Annual General Meetings) to 14 clear days' notice

1,707,233,520

94.09%

107,229,423

5.91%

1,814,462,943

73.88%

2,631,807

 

Resolution 2: 2024 Directors' Remuneration Report

 

While the Board is pleased that all resolutions were supported by a significant majority of shareholders, Resolution 2 was approved with a 72.29% majority. 

 

The Board has actively engaged with shareholders over the last year in respect of a range of governance matters. That dialogue has helped the Board to build a more detailed understanding of shareholder views, and in turn, for shareholders to gather additional context to support understanding of the Board's decisions. In the months ahead, we will continue to engage and in line with the UK Corporate Governance Code, Unilever will publish a further statement detailing the outcome of those engagements, including any actions taken as a result, within six months of today's Annual General Meeting.

 

NOTES:

- The 'For' vote includes votes given at the Chair's discretion and details of proxy votes cast are included in the table above.

- As at close of business on 29 April 2025 the total number of issued ordinary shares of Unilever PLC was 2,524,997,338. Of those ordinary shares, 67,246,885 were held as treasury shares and 1,884,648 ordinary shares (including ordinary shares represented by Unilever PLC ADSs) were held by or on behalf of companies in the Unilever Group (the "Unilever Group Shares"). The voting rights attaching to the Unilever Group Shares are not exercisable. Therefore, as at 11.30am on 30 April 2025, the total number of Unilever PLC ordinary shares with exercisable voting rights was 2,455,865,805.

 

A 'Vote withheld' is not a vote in law and will not be counted in the calculation of the proportion of the votes 'for' and 'against' a resolution.

 

In accordance with UK Listing Rule 6.4.2 copies of all the resolutions passed, other than ordinary business, will be submitted to and available for inspection at the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism. A copy of the resolutions can also be found in the Chair's Letter and Notice of Meeting which is available on our website: www.unilever.com/AGM.

 

30 April 2025

 

Cautionary Statement:

This announcement may contain forward-looking statements within the meaning of the securities laws of certain jurisdictions, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Words and terminology such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', 'ambition', 'target', 'goal', 'plan', 'potential', 'work towards', 'may', 'milestone', 'objectives', 'outlook', 'probably', 'project', 'risk', 'continue', 'should', 'would be', 'seeks', or the negative of these terms and other similar expressions of future performance, results, actions or events, and their negatives, are intended to identify such forward-looking statements. Forward-looking statements also include, but are not limited to, statements and information regarding Unilever's emissions reduction and other sustainability-related targets and other climate and sustainability matters (including actions, potential impacts and risks and opportunities associated therewith). Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of the Unilever Group (the "Group") (including during management presentations) in connection with this announcement. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Group. They are not historical facts, nor are they guarantees of future performance or outcomes. All forward-looking statements contained in this announcement are expressly qualified in their entirety by the cautionary statements contained in this section. Readers should not place undue reliance on forward-looking statements.

Because these forward-looking statements involve known and unknown risks and uncertainties, a number of which may be beyond the Group's control, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially from the forward-looking statements expressed in this announcement are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; the effect of climate change on Unilever's business; Unilever's ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in Unilever's supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high-quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects, including the proposed separation of our Ice Cream business; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters and practices with regard to the interpretation and application thereof and emerging and developing ESG reporting standards including differences in implementation of climate and sustainability policies in the regions where the Group operates.

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. Forward-looking statements are not predictions of future events. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

The forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any intention, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. New risks and uncertainties arise over time, and it is not possible for us to predict those events or how they may affect us. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual events, to differ materially from those contained in any forward-looking statements. Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2024 and the Unilever Annual Report and Accounts 2024.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGEBLFXEZLBBBE
Date   Source Headline
19th Jun 20262:23 pmRNSDirector/PDMR Shareholding
10th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20266:17 pmRNSCompletion of 2026 Share Buyback
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20265:13 pmRNSTotal Voting Rights
1st Jun 202610:37 amRNSDirector/PDMR Shareholding
1st Jun 202610:29 amRNSTotal Voting Rights
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
18th May 20264:35 pmRNSDirector/PDMR Shareholding
15th May 20265:45 pmRNSPublication of Information Memorandum
15th May 20265:07 pmRNSPublication of UFN Financial Statements
13th May 20263:54 pmRNSResult of AGM
13th May 20267:00 amRNSTransaction in Own Shares
6th May 20265:49 pmRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20263:08 pmRNSTotal Voting Rights
30th Apr 20267:01 amRNSShare Buy-Back Programme
30th Apr 20267:00 amRNSQ1 2026 Trading Statement
20th Apr 20261:58 pmRNSDirector/PDMR Shareholding
1st Apr 20264:42 pmRNSTotal Voting Rights
31st Mar 20263:00 pmRNSNotice of AGM
31st Mar 20261:00 pmRNSUnilever Foods and McCormick Agreement
31st Mar 20267:00 amRNSResponse to Media Speculation
20th Mar 20267:00 amRNSResponse to media speculation
6th Mar 20264:21 pmRNSDirector/PDMR Shareholding
6th Mar 20264:09 pmRNSPortfolio Update
2nd Mar 20265:50 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSGroup Company Secretary Change
19th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Feb 20264:38 pmRNSDirector/PDMR Shareholding
16th Feb 20264:26 pmRNSDirector/PDMR Shareholding
13th Feb 20264:57 pmRNSDirector Declaration
12th Feb 20265:11 pmRNSPublication of Supplement
12th Feb 20267:00 amRNS2025 Full Year Results
5th Feb 20264:06 pmRNSNotification of issuance of equity securities
2nd Feb 20264:14 pmRNSTotal Voting Rights
8th Jan 202610:17 amRNSTotal Voting Rights
2nd Jan 20265:21 pmRNSTotal Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSCancellation of Treasury Shares
10th Dec 202511:29 amRNSDirector/PDMR Shareholding
8th Dec 20255:51 pmRNSUpdate on Share Consolidation
8th Dec 20257:00 amRNSCompletion of demerger of Ice Cream Business
5th Dec 20257:00 amRNSDemerger of Unilever’s Ice Cream Business
3rd Dec 20252:50 pmRNSCancellation of Treasury Shares
1st Dec 20256:22 pmRNSTotal Voting Rights
19th Nov 202512:23 pmRNSDirector/PDMR Shareholding
12th Nov 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.